https://phys.org/news/2023-01-alphafold-ai-drug-liver-cancer.html
0
0
56 words
0
Comments
New research uses AlphaFold, an artificial intelligence (AI)-powered protein structure database, to accelerate the design and synthesis of a drug to treat hepatocellular carcinoma (HCC), the most common type of primary liver cancer. It is the first successful…
You are the first to view
Create an account or login to join the discussion